The Department of Health and Human Services, led by Robert F. Kennedy Jr., has canceled significant federal funding for Moderna's influenza mRNA vaccine development due to concerns about safety and the thoroughness of testing. Initially, the Biden administration granted $176 million for vaccine development and an additional $590 million shortly before leaving office. Following promising preliminary trial results of Moderna's H5 influenza vaccine, HHS stated the decision reflects a commitment to vaccine safety and integrity, contrasting with past practices where safety issues were allegedly overlooked.
"This is not simply about efficacy-it's about safety, integrity, and trust," said HHS spokesperson Andrew Nixon, emphasizing a cautious approach toward mRNA vaccine testing.
Nixon argued that the previous administration concealed legitimate safety concerns regarding mRNA vaccines, highlighting the need for transparent testing processes going forward.
Collection
[
|
...
]